FY25 Full Year Results and Strategy Update
Dr. Martens plc will release its FY25 Full Year Results presentation and a Strategy update presentation on Thursday 5th June at 07:00am and 10:30am (BST) respectively. Please register for the events using the links below.
Why invest
We have a number of competitive strengths which act as differentiators and position the business for growth.
>60
years of heritage
61%
Revenue from DTC
£877.1m
Revenue
7%
Average Annual Revenue Growth Since FY201
11.5
million pairs sold
60+
countries operated in
£197.5m
EBITDA
22.5%
EBITDA margin
Source: DM Audited Accounts, Company data.
Note: March financial year end. All figures are FY24, unless otherwise specified.
1. FY20 - FY24 CAGR